Europe Home Care Market Growth & Trends
The Europe home care market size is expected to reach USD 192.86 billion by 2030 and is anticipated to grow at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The Europe home care market is experiencing substantial growth driven by a confluence of demographic, economic, and technological factors. A key driver is the increasing geriatric population, contributing to a higher incidence of chronic diseases. The European Commission's 2024 Ageing Report projected a rise in public spending on healthcare and long-term care to 25.6% of the EU's GDP by 2070, underscoring the escalating demand for care services.
Technological advancements in medical devices have significantly propelled market expansion, alongside the rising prevalence of chronic conditions and the cost-effectiveness of home care solutions. This has increased the acceptance of home care as a preferable alternative to institutional settings. The availability of user-friendly portable devices, such as heart rate and glucose monitors, has enhanced the efficiency of managing lifestyle diseases at home. The growing prevalence of respiratory illnesses, including asthma, COPD, and sleep apnea, fueled by air pollution and lifestyle choices, is also a major catalyst for the respiratory care devices market within the home care sector.
The EU4Health Programme is a significant example of initiatives strengthening European health systems by promoting the digital transformation of healthcare, which is crucial for expanding remote care solutions and improving accessibility. Complementing this, the stringent European regulatory environment ensures the safety and efficacy of medical devices used in home care throughout their lifecycle. These interconnected factors collectively contribute to the robust growth of the Europe home care market.
Europe Home Care Market Report Highlights
- The service segment held the largest market share of over 80.0% in 2024
- Home care equipment is anticipated to witness the fastest growth over the forecast period, driven by the shift to home-based care, technological advancements, and cost-saving incentives
- Cancer care held the largest share in the indication segment due to Europe's aging population and rising cancer cases, projected to increase by 31% and 35% by 2025, respectively
- The growth of the European home care market is driven by an aging population, a rising demand for personalized in-home services, and innovations in telehealth and medical technologies
- Germany dominated the Europe home care market in 2024 owing to factors such as chronic disease prevalance, technological advancements, and government support
- In August 2024, Medtronic received FDA approval for Simplera, a more compact and disposable version of its continuous glucose monitor, and entered into a global partnership with Abbott to expand CGM options for people living with diabetes
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Component
- 1.2.2. Indication
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Indication outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Europe Home Care Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Europe Home Care Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Europe Home Care Market: Component Estimates & Trend Analysis
- 4.1. Component Segment Dashboard
- 4.2. Europe Home Care Market: Component Movement Analysis
- 4.3. Europe Home Care Market Size & Trend Analysis, by Component, 2018 to 2030 (USD Million)
- 4.4. Equipment
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Therapeutic
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.2. Home Respiratory Equipment
- 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.3. Insulin Delivery Market
- 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.4. Home IV Pumps
- 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.5. Home Dialysis Equipment
- 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.6. Other Therapeutic Equipment
- 4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Diagnostic
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.2. Diabetic Care Unit
- 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.3. BP Monitors
- 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.4. Multi Para Diagnostic Monitors
- 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.5. Home Pregnancy and Fertility Kits
- 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.6. Apnea and Sleep Monitors
- 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.7. Holter Monitors
- 4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.8. Heart Rate Meters (Include Pacemakers)
- 4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3.9. Others
- 4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Mobility Assist
- 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4.2. Wheelchair
- 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4.3. Home Medical Furniture
- 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4.4. Walking Assist Devices
- 4.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Services
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Skilled Nursing Services
- 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.2. Physician Primary Care
- 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.3. Nursing Care
- 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.4. Physical/Occupational/Speech Therapy
- 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.5. Nutritional Support
- 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.6. Hospice & Palliative
- 4.5.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.7. Other Skilled Nursing Services
- 4.5.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Unskilled Nursing Services
- 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Europe Home Care Market: Indication Estimates & Trend Analysis
- 5.1. Indication Segment Dashboard
- 5.2. Europe Home Care Market: Indication Movement Analysis
- 5.3. Europe Home Care Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
- 5.4. Cardiovascular Disorder & Hypertension
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Diabetes & Kidney Disorders
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Neurological & Mental Disorders
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Respiratory Disease & COPD
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Maternal Disorders
- 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.9. Mobility Disorders
- 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.10. Cancer
- 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.11. Wound Care
- 5.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.12. Others
- 5.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Europe Home Care Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Dashboard
- 6.2. Regional Market Share Analysis, 2024 & 2030
- 6.3. Europe home care market by Region: Key Takeaways
- 6.4. UK
- 6.4.1. Key country dynamics
- 6.4.2. Regulatory framework/ reimbursement structure
- 6.4.3. Competitive scenario
- 6.4.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Germany
- 6.5.1. Key country dynamics
- 6.5.2. Regulatory framework/ reimbursement structure
- 6.5.3. Competitive scenario
- 6.5.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Sweden
- 6.6.1. Key country dynamics
- 6.6.2. Regulatory framework/ reimbursement structure
- 6.6.3. Competitive scenario
- 6.6.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. France
- 6.7.1. Key country dynamics
- 6.7.2. Regulatory framework/ reimbursement structure
- 6.7.3. Competitive scenario
- 6.7.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Italy
- 6.8.1. Key country dynamics
- 6.8.2. Regulatory framework/ reimbursement structure
- 6.8.3. Competitive scenario
- 6.8.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. Russia
- 6.9.1. Key country dynamics
- 6.9.2. Regulatory framework/ reimbursement structure
- 6.9.3. Competitive scenario
- 6.9.4. Russia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.10. Netherlands
- 6.10.1. Key country dynamics
- 6.10.2. Regulatory framework/ reimbursement structure
- 6.10.3. Competitive scenario
- 6.10.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
- 6.11. Spain
- 6.11.1. Key country dynamics
- 6.11.2. Regulatory framework/ reimbursement structure
- 6.11.3. Competitive scenario
- 6.11.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.12. Portugal
- 6.12.1. Key country dynamics
- 6.12.2. Regulatory framework/ reimbursement structure
- 6.12.3. Competitive scenario
- 6.12.4. Portugal market estimates and forecasts 2018 to 2030 (USD Million)
- 6.13. Belgium
- 6.13.1. Key country dynamics
- 6.13.2. Regulatory framework/ reimbursement structure
- 6.13.3. Competitive scenario
- 6.13.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key company heat map analysis, 2024
- 7.4. Company Profiles
- 7.4.1. Siemens Healthineers AG
- 7.4.1.1. Company overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Medtronic
- 7.4.2.1. Company overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. Health Care At Home Private Limited
- 7.4.3.1. Company overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. BAYADA Home Health Care
- 7.4.4.1. Company overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. Inizio
- 7.4.5.1. Company overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Accredo Health Group, Inc.
- 7.4.6.1. Company overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. Mears Group PLC
- 7.4.7.1. Company overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. OMRON Corporation
- 7.4.8.1. Company overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. Johnson & Johnson Medical Limited
- 7.4.9.1. Company overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. DomusVi Group
- 7.4.10.1. Company overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook